Search
for
Sort by
Research 841–870 of 1000+
- Excimer Light versus Combination of Tacrolimus and Excimer Light in the Treatment of Alopecia Areata
- Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Society of Dermatology. Part 2: Treatment
- Dermatoscopic evaluation of alopecia areata
- Soluble CD83 reverses alopecia areata via IDO-mediated Treg cell activation
- Alopecia Areata: Unseen Burdens and Unmet Needs – Comment on ‘The most impactful aspects of living with alopecia areata among patients commencing systemic treatments: Evaluating patients’ perspectives to guide therapy’
- Role of Aire and Notch4 Allelic Mutations in Alopecia Areata in C3H/HeJ Mice
- INVESTIGATION OF SOME BIOMARKERS FOR ENTEROCOCCUS FAECALIS WITH ALOPECIA AREATA PATIENTS
- 93 Approach to Managing Recalcitrant Alopecia Areata With Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Is Intralesional Methotrexate an Effective Alternative to Intralesional Triamcinolone in Alopecia Areata? Findings From a Randomized Controlled Trial
- Traversing the Pathway and Exploring the Link—A Clinical and Epidemiological Study in Alopecia Areata and Its Association with Autoimmune Diseases
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Predictive factors for treatment responses to baricitinib in severe alopecia areata: A retrospective, multivariate analysis of 70 cases from a single center
- Evidence-Based Data on How Long to Treat to Achieve Treatment Response With Baricitinib in Severe Alopecia Areata
- Combination Therapy With CGF and Microneedling‐Assisted Compound Betamethasone for Resistant Alopecia Areata: APilot Study
- 53274 Real-world experience of efficacy and safety of baricitinib in Korean patients with severe alopecia areata
- Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
- Evaluating the Effect of the Demographic, Trichoscopic and Laboratory Characteristics on The Recurrence of Alopecia Areata
- 42227 Efficacy and Predictive Factors of Systemic Corticosteroid in Alopecia Areata: Reappraisal of Oral Methylprednisolone Tapering Treatment
- 474 The influence of alopecia areata on quality of life: A cross-sectional study in Bangladesh
- Trichoscopy pattern and evaluation of serum vitamin D status in alopecia areata
- Sustained hair regrowth with ritlecitinib to Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study
- Alopecia Areata: A Case Report
- The Efficacy of Azelaic Acid 20% Cream in the Treatment of Scalp Alopecia Areata
- Eosinophilia versus atopy as a predictor of severe phenotypes in alopecia areata
- A randomised open label comparative study of hydroxychloroquine with betamethasone oral minipulse in the management of patients with alopecia areata.
- Analysis of alopecia areata surveys suggests a threshold for improved patient-reported outcomes
- Alopecia areata - need for a revision in morphological classification and scoring
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- Diagnosis and treatment of alopecia areata